Latest Insider Transactions at Cigna Corp (CI)
This section provides a real-time view of insider transactions for Cigna Corp (CI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cigna Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cigna Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2021
|
David Cordani Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,956
+18.46%
|
-
|
|
Feb 24
2021
|
Noelle K Eder Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,947
+25.13%
|
-
|
|
Feb 24
2021
|
Brian C Evanko Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,929
+17.42%
|
-
|
|
Feb 24
2021
|
Nicole S Jones Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,900
+9.45%
|
-
|
|
Feb 24
2021
|
John M Murabito EVP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,548
+5.2%
|
-
|
|
Feb 24
2021
|
Kristen Lauria EVP Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,170
+32.01%
|
-
|
|
Feb 24
2021
|
Matthew G Manders Pres, Government and Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
5,219
+10.26%
|
-
|
|
Feb 24
2021
|
Eric P Palmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,034
+15.62%
|
-
|
|
Feb 24
2021
|
Steven B Miller EVP, Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,287
+4.46%
|
-
|
|
Feb 24
2021
|
Michael W Triplett Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
2,690
+10.73%
|
-
|
|
Feb 24
2021
|
Jason D Sadler Pres., International Health |
BUY
Grant, award, or other acquisition
|
Direct |
2,555
+8.35%
|
-
|
|
Feb 24
2021
|
Everett Neville EVP, Solutions & Corp Devt. |
BUY
Grant, award, or other acquisition
|
Direct |
2,456
+20.0%
|
-
|
|
Feb 24
2021
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
585
+7.89%
|
-
|
|
Feb 11
2021
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,950
+2.83%
|
$132,600
$68.38 P/Share
|
|
Feb 10
2021
|
Nicole S Jones Officer |
SELL
Open market or private sale
|
Direct |
9,275
-22.74%
|
$1,966,300
$212.32 P/Share
|
|
Feb 10
2021
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,275
+10.13%
|
$630,700
$68.38 P/Share
|
|
Feb 08
2021
|
Timothy C Wentworth CEO Evernorth |
SELL
Open market or private sale
|
Indirect |
5,144
-6.27%
|
$1,049,376
$204.86 P/Share
|
|
Feb 04
2021
|
Steven B Miller EVP, Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
622
-2.31%
|
$130,620
$210.53 P/Share
|
|
Feb 04
2021
|
Timothy C Wentworth CEO Evernorth |
SELL
Payment of exercise price or tax liability
|
Direct |
4,554
-9.69%
|
$956,340
$210.53 P/Share
|
|
Jan 22
2021
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,772
+19.21%
|
$798,776
$58.73 P/Share
|
|
Jan 21
2021
|
Jason D Sadler Pres., International Health |
SELL
Open market or private sale
|
Direct |
2,000
-7.28%
|
$460,000
$230.04 P/Share
|
|
Jan 21
2021
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
55,176
-55.54%
|
$12,690,480
$230.0 P/Share
|
|
Jan 21
2021
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
55,176
+35.71%
|
$3,200,208
$58.73 P/Share
|
|
Jan 21
2021
|
Matthew G Manders Pres, Government and Solutions |
SELL
Open market or private sale
|
Direct |
5,596
-12.16%
|
$1,287,080
$230.06 P/Share
|
|
Jan 13
2021
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,667
+23.63%
|
$792,686
$58.73 P/Share
|
|
Jan 12
2021
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
55,280
-64.45%
|
$12,438,000
$225.0 P/Share
|
|
Jan 12
2021
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
55,280
+39.19%
|
$3,206,240
$58.73 P/Share
|
|
Jan 07
2021
|
Steven B Miller EVP, Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
777
+2.81%
|
$124,320
$160.66 P/Share
|
|
Jan 06
2021
|
Steven B Miller EVP, Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
8,972
-25.58%
|
$1,884,120
$210.0 P/Share
|
|
Jan 06
2021
|
Steven B Miller EVP, Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,972
+20.37%
|
$1,435,520
$160.66 P/Share
|
|
Dec 28
2020
|
Timothy C Wentworth CEO Evernorth |
SELL
Open market or private sale
|
Indirect |
3,849
-4.01%
|
$777,498
$202.7 P/Share
|
|
Dec 18
2020
|
John M Murabito EVP & Chief Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,816
+3.97%
|
$217,920
$120.89 P/Share
|
|
Dec 17
2020
|
John M Murabito EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
13,986
-24.94%
|
$2,839,158
$203.31 P/Share
|
|
Dec 17
2020
|
John M Murabito EVP & Chief Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,986
+19.96%
|
$1,678,320
$120.89 P/Share
|
|
Dec 07
2020
|
Michael W Triplett Special Advisor |
SELL
Bona fide gift
|
Direct |
200
-1.01%
|
-
|
|
Dec 01
2020
|
Timothy C Wentworth CEO Evernorth |
BUY
Bona fide gift
|
Indirect |
3,849
+10.46%
|
-
|
|
Dec 01
2020
|
Timothy C Wentworth CEO Evernorth |
SELL
Bona fide gift
|
Direct |
3,849
-7.57%
|
-
|
|
Nov 30
2020
|
William J De Laney Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
227
+1.11%
|
-
|
|
Nov 30
2020
|
Eric J Foss Director |
BUY
Grant, award, or other acquisition
|
Direct |
227
+0.7%
|
-
|
|
Nov 30
2020
|
Elder Granger Director |
BUY
Grant, award, or other acquisition
|
Direct |
227
+7.37%
|
-
|
|
Nov 30
2020
|
Isaiah Harris Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
274
+1.43%
|
-
|
|
Nov 30
2020
|
Roman Iv Martinez Director |
BUY
Grant, award, or other acquisition
|
Direct |
227
+0.46%
|
-
|
|
Nov 30
2020
|
Kathleen M Mazzarella Director |
BUY
Grant, award, or other acquisition
|
Direct |
227
+8.87%
|
-
|
|
Nov 30
2020
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
227
+8.87%
|
-
|
|
Nov 30
2020
|
John Partridge Director |
BUY
Grant, award, or other acquisition
|
Direct |
227
+0.84%
|
-
|
|
Nov 30
2020
|
William L Roper Director |
BUY
Grant, award, or other acquisition
|
Direct |
227
+2.64%
|
-
|
|
Nov 30
2020
|
Kimberly A. Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
227
+23.62%
|
-
|
|
Nov 30
2020
|
Donna F Zarcone Director |
BUY
Grant, award, or other acquisition
|
Direct |
227
+0.91%
|
-
|
|
Nov 30
2020
|
Eric C Wiseman Director |
BUY
Grant, award, or other acquisition
|
Direct |
227
+1.16%
|
-
|
|
Nov 11
2020
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,288
+5.07%
|
$628,672
$44.42 P/Share
|